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Introduction
Psychopharmaceutical medications are noted for being one of the most commonly prescribed drugs worldwide, 1 which makes the issue of overprescribing them such a heated topic in medicine and psychiatry today. As a clear evidence of their overuse, the last decade or so has witnessed a significant growth in the dispensing of psychotropic drugs in Australia, with an over 58% rate of increase from the years 2000 to 2011. 2 Additionally, the use of psychopharmaceutical drugs is seen to be ballooning in almost all industrialized nations of the world. For example, in France, which has the highest consumption rate globally, a quarter of the population is using at least one psychotropic agent, 3 which shows that it is indeed an international issue with potentially serious ramifications on the safety of patients and the cost of healthcare worldwide.
Therefore, it is not an exaggeration to say that this issue should interest and concern the governments and healthcare authorities along with health professionals and lay people.
Antidepressants
Antidepressants, in particular, offer the most apparent example of psychopharmaceutical overprescription, given their widespread use: they alone represent nearly 5% of all medications prescribed in primary care in Australia. 4 This class of drugs is also dispensed more rapidly than any other class of psychotropic medications, with an almost two-fold increase since the start of this century. 2 This could be attributed to an upsurge in the incidence of depression, increased public awareness regarding it, or both. 5 
Adverse consequences
Overuse of psychiatric medications, including the aforementioned antidepressants, does not come without a cost. In fact, it is a hefty cost indeed.
Numerous and significant harms can manifest with it, most obviously the financial burden on the patient and the taxpayers alike, 12 as well as opportunity costs, where the chances of clinicians and patients working together to find alternative treatment are cut short and might even be completely neglected. 13 In addition, adverse iatrogenic outcomes of pharmacological agents, including toxicity and unpleasant side effects, should always be considered, especially concerning the most vulnerable demographics of the population.
In fact, a massive study involving 60,000 people older than 65 years of age has concluded that the absolute risks for all-cause mortality over 1 year increase with the use of antidepressants. 14 It should be noted here that this was a population-based cohort study, which makes it more prone to confounders and bias, such as channeling bias; however, this does not completely discard the conclusions drawn from the study. 
Conclusion
The 
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